Full Text
PCN5 ANALYSIS OF OVER 2400 MODERN PHASE I CANCER TRIALS- COMPOSITION, OUTCOMES, AND USE OF SURROGATE ENDPOINTS

Abstract

Authors

TG Roberts BHL Goulart SC Stallings L Squitieri BA Chabner SN Finkelstein JW Clark

Back to Volume 7, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×